Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings

Shares (Q2 2026)
213
Value
$5.48K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of DNLI by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026213$5.48K<0.1%−145−40.5%ReducedHolders
Q1 2026358$6.87K<0.1%00.0%UnchangedHolders
Q4 2025358$5.91K<0.1%−76−17.5%ReducedHolders
Q3 2025434$6.30K<0.1%−111−20.4%ReducedHolders
Q2 2025545$7.63K<0.1%+383+236.4%AddedHolders
Q1 2025162$2.20K<0.1%+63+63.6%AddedHolders
Q4 202499$2.02K<0.1%−13−11.6%ReducedHolders
Q3 2024112$3.26K<0.1%00.0%UnchangedHolders
Q2 2024112$2.60K<0.1%−304−73.1%ReducedHolders
Q1 2024416$8.54K<0.1%+333+401.2%AddedHolders
Q4 202383$1.78K<0.1%−237−74.1%ReducedHolders
Q3 2023320$6.60K<0.1%+292+1,042.9%AddedHolders
Q2 202328$826<0.1%−3−9.7%ReducedHolders
Q1 202331$714<0.1%+31NewHolders
Q4 20220$00.0%−10−100.0%Sold outHolders
Q3 202210$00.0%00.0%UnchangedHolders
Q2 202210$00.0%+8+400.0%AddedHolders
Q1 20222$00.0%−44−95.7%ReducedHolders
Q4 202146$2.00K<0.1%+20+76.9%AddedHolders
Q3 202126$1.00K<0.1%+26NewHolders
Q2 20210$00.0%−12−100.0%Sold outHolders
Q1 202112$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.